About Ception Therapeutics
Ception Therapeutics is a company based in Malvern (United States) founded in 2004 was acquired by Cephalon in February 2010. Ception Therapeutics has raised $77.7 million across 2 funding rounds from investors including Cephalon, GreenLight Capital and Growth Capital Fund. Ception Therapeutics offers products and services including Payroll Outsourcing and Payroll Services. Ception Therapeutics operates in a competitive market with competitors including Aclaris Therapeutics, argenx, Escient Pharmaceuticals, MacroGenics and Nimbus Therapeutics, among others.
- Headquarter Malvern, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Ception Therapeutics, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ception Therapeutics
Ception Therapeutics offers a comprehensive portfolio of products and services, including Payroll Outsourcing and Payroll Services.
Service for managing payroll to improve data security and efficiency
Expert solutions for wage and tax handling in businesses
Funding Insights of Ception Therapeutics
Ception Therapeutics has successfully raised a total of $77.7M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $14.7 million completed in May 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ception Therapeutics
Ception Therapeutics has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Cephalon, GreenLight Capital and Growth Capital Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Early, mid, and late-stage investments are made in science sectors.
|
Locked | Locked | Locked | |
|
A healthcare-focused investment firm supporting innovative company growth.
|
Locked | Locked | Locked |
Investor details for Ception Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ception Therapeutics
Investment portfolio details for Ception Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ception Therapeutics
Detailed financials for Ception Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ception Therapeutics Comparisons
Peer comparison for Ception Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ception Therapeutics
Ception Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aclaris Therapeutics, argenx, Escient Pharmaceuticals, MacroGenics and Nimbus Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel dermatologic therapies are developed for skin conditions.
|
|
| Locked | Locked | Locked |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company focused on cancer therapeutics development.
|
|
| Locked | Locked | Locked |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of immunotherapies to treat cancer and autoimmune disorders
|
Detailed competitors of Ception Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ception Therapeutics
Complete news archive for Ception Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ception Therapeutics
Ception Therapeutics was founded in 2004 and raised its 1st funding round 3 years after it was founded.
Ception Therapeutics is headquartered in Malvern, United States. It is registered at Malvern, Pennsylvania, United States.
Ception Therapeutics is a funded company, having raised a total of $77.7M across 2 funding rounds to date.
Ception Therapeutics was established in 2004 in Malvern, United States, within the biotechnology sector. Focus is placed on discovering, developing, and commercializing treatments for inflammatory conditions. Reslizumab, a monoclonal antibody, is targeted at eosinophilic disorders. Small-molecule Anti-TNF receptor agents, suitable for oral administration, are also pursued. Since February 2010, the entity has functioned as a subsidiary of Cephalon.
Ception Therapeutics's top competitors include argenx, Escient Pharmaceuticals and Nimbus Therapeutics.
Ception Therapeutics offers Payroll Outsourcing and Payroll Services.
Ception Therapeutics has 6 investors. Key investors include Cephalon, GreenLight Capital, Growth Capital Fund, New Science Ventures, and Aperture Venture Partners.